Picture of DSM-Firmenich AG logo

DSFIR — DSM-Firmenich AG News Story

0.000.00%
nl flag iconLast trade - 00:00
IndustrialsBalancedLarge Cap

Brief: Dsm-firmenich Q3 Results Beat Consensus, 2026 Growth Outlook Lifted

BRIEF-Dsm-firmenich Q3 Results Beat Consensus, 2026 Growth Outlook Lifted

- DSM-Firmenich AG DSFIR.AS:

  • DSM-FIRMENICH REPORTS Q3 2026 TRADING UPDATE

  • Q3 TOTAL SALES €2.37 BILLION (DSM-PROVIDED CONSENSUS: €2,355 MILLION)

  • Q3 ADJUSTED EBITDA €482 MILLION (DSM-PROVIDED CONSENSUS: €478 MILLION)

  • Q3 ORGANIC SALES GROWTH 5% (DSM-PROVIDED CONSENSUS: 4.7%)

  • Q3 ADJUSTED EBITDA MARGIN 20.4% (DSM-PROVIDED CONSENSUS: 20.3%)

  • FY 2026 OUTLOOK: LFL SALES GROWTH INCREASED TO AROUND 5% (PREVIOUSLY 2-4%)

  • REITERATES OUTLOOK 2026 FOR ADJUSTED EBITDA MARGIN AT AROUND 20%

Source text: ID: nGNE2HYpVS

Further company coverage: DSFIR.AS


(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00; ))

Recent news on DSM-Firmenich AG

See all news